Beijing Continent Pharmaceutical Co, Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   [¹⁴C] Hydronidone Mass Balance Study

   Completed without a posted recruiting period

   Also in this update: Final enrollment: 6 participants (planned 8); Primary completion date changed from estimate of Jul 30, 2026 to May 6, 2026

   Beijing Continent Pharmaceutical Co, Ltd.·Phase 1· NCT07471217· Registry history of NCT07471217 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

2. Minor

   Ⅰd Clinical Trial of Hydronidone Capsules

   Completed without a posted recruiting period

   Beijing Continent Pharmaceutical Co, Ltd.·Phase 1· NCT07262346· Registry history of NCT07262346 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.